Search Results 1391-1400 of 17182 for monoclonal antibody

1. A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression - Mayo Clinic

   Patients with prior hypersensitivity to monoclonal antibodies. Women who are pregnant or lactating. Patients with prior treatment with MIRV or other FRα ...

2. PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies - Mayo Clinic

   ... antibody (HBcAb), or hepatitis C virus (HCV) antibody (unless HCV viral load test by polymerase chain reaction is negative). HBcAb positivity will be ...

3. Night sweats Causes - Mayo Clinic

   Menopause hormone therapy: Does it cause vaginal bleeding? Hormone therapy · Monoclonal antibody drugs · Mononucleosis · Mononucleosis: Can it recur ...

4. Donor-derived Cell-free DNA Testing in Kidney Transplant Recipients on Reduced Immunosuppression - Mayo Clinic

   ... antibody (DSA) or increase in preexisting DSA's in presence of elevated dd-cfDNA, and to determine the association of elevated dd-cfDNA with progression of ...

5. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

   Prior treatment ≤ 21 days prior to registration/randomization with any other chemotherapy, small molecule inhibitor (e.g., regorafenib), monoclonal antibody, ...

6. Guidance Needed on PDL1-Inhibitors

   ... antibodies that typically attach to viruses and bacteria to mark them as immune targets. These antibodies work the same way in cancer, to prevent cancer ...

7. Granulomatosis With Polyangiitis Clinical Trials - Mayo Clinic Research

   ... antibody (ANCA)-associated vasculitis (AAV). PR3-AAV Resilient Remission or PRRR Rochester, MN. The purpose of this study is to determine the proportion of ...

8. Cancer Clinical Trials - Medical Professionals

   The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs ...

9. The Impact of Clinical Trials in Patients with Multiple Myeloma and Lymphoma

   Patients on single agent anti-CD20 antibodies alone; ECOG performance status 3 or worse; ANC < 1000; Inadequate organ function (bilirubin > 2x UNL, GFR < 30 ml ...

10. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    NOTE: Patients with antibody to hepatitis B core antibody are eligible if they have no measurable viral titer. Patients who have had a hepatitis B virus ...